Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)138-141
Number of pages4
JournalHereditary Cancer in Clinical Practice
Volume5
Issue number3
StatePublished - Sep 15 2007

Fingerprint

Taxoids
Breast Neoplasms
Mutation

All Science Journal Classification (ASJC) codes

  • Oncology
  • Genetics(clinical)
  • Cancer Research

Cite this

Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers. / Smeltzer, Jacob; Silberstein, Peter T.; Lynch, Henry T.

In: Hereditary Cancer in Clinical Practice, Vol. 5, No. 3, 15.09.2007, p. 138-141.

Research output: Contribution to journalComment/debate

@article{8786bcb5844d46708b75a5dfae69787f,
title = "Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers",
author = "Jacob Smeltzer and Silberstein, {Peter T.} and Lynch, {Henry T.}",
year = "2007",
month = "9",
day = "15",
language = "English",
volume = "5",
pages = "138--141",
journal = "Hereditary Cancer in Clinical Practice",
issn = "1731-2302",
publisher = "BioMed Central",
number = "3",

}

TY - JOUR

T1 - Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers

AU - Smeltzer, Jacob

AU - Silberstein, Peter T.

AU - Lynch, Henry T.

PY - 2007/9/15

Y1 - 2007/9/15

UR - http://www.scopus.com/inward/record.url?scp=35348877217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348877217&partnerID=8YFLogxK

M3 - Comment/debate

VL - 5

SP - 138

EP - 141

JO - Hereditary Cancer in Clinical Practice

JF - Hereditary Cancer in Clinical Practice

SN - 1731-2302

IS - 3

ER -